Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2013
08/13/2013US8506813 Bidirectional transfer of an aliquot of fluid between compartments
08/13/2013US8506775 Devices and methods relating to electrochemical biosensors
08/13/2013US8506740 Manufacturing electrochemical sensor module
08/13/2013US8506407 Gaming system network and method for delivering gaming media
08/13/2013US8506406 Network access device and method to run a game application
08/13/2013US8505397 Methods of characterizing aluminum oxides
08/13/2013US8505276 Particulate matter measurement device
08/13/2013DE202012012671U1 Messmodi automatisch erkennendes Multifunktionsmessgerät und Teststreifen desselben The same measurement modes automatically be recognized multifunction meter and test strips
08/13/2013CA2709871C Polymer precursors of radiolabeled compounds, and methods of making and using the same
08/13/2013CA2642150C Total organic carbon analysis with diamond-coated electrodes
08/13/2013CA2565676C Gm3 synthase as a therapeutic target in microvascular complications of diabetes
08/13/2013CA2543406C Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption
08/13/2013CA2529941C Method for identification of tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof
08/13/2013CA2527534C Packaging of microfluidic devices
08/13/2013CA2525781C Method for the prediction, diagnosis and differential diagnosis of alzheimer's disease
08/13/2013CA2516777C Human cyclooxygenase-3 enzyme and uses thereof
08/13/2013CA2498524C Immunoassays for specific determination of scca isoforms
08/13/2013CA2489177C A disposable cartridge for characterizing particles suspended in a liquid
08/13/2013CA2469151C Immunocytokines with modulated selectivity
08/13/2013CA2464121C Pregnancy-associated plasma protein-a2 (papp-a2)
08/13/2013CA2413003C Immunoassays for anti-hcv antibodies
08/13/2013CA2382545C Methods for encoding and sorting in vitro translated proteins
08/13/2013CA2372582C Novel fab fragment libraries and methods for their use
08/13/2013CA2273847C Diagnosis of disease state using mrna profiles
08/13/2013CA2258277C Characterization of granulocytic ehrlichia and methods of use
08/13/2013CA2225377C Novel tgf-.beta. like cytokine
08/13/2013CA2222643C Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
08/08/2013WO2013116847A1 Extraction of mycotoxins
08/08/2013WO2013116834A2 Microfluidic device for generating neural cells to simulate post-stroke conditions
08/08/2013WO2013116827A1 Diagnosis and treatment of functional dyspepsia and irritable bowel syndrome
08/08/2013WO2013116799A1 System and method for monitoring asset health by dissolved gas measurement
08/08/2013WO2013116742A1 Predicting responses to androgen deprivation therapy and methods for treating prostate cancer
08/08/2013WO2013116735A1 Methods for predicting tumor response to targeted therapies
08/08/2013WO2013116686A1 Methods and products related to targeted cancer therapy
08/08/2013WO2013116669A1 Status displaying sample carrier
08/08/2013WO2013116638A1 Intelligent bidirectional multifunctional carrier and integrated automation system for material distribution and transportation
08/08/2013WO2013116590A1 Inhibition of pattern recognition receptors in pancreatic cancer treatment using tlr inhibitors
08/08/2013WO2013116547A1 Implantable device and methods for diagnosing heart failure using biomarker panel data
08/08/2013WO2013116544A1 Systems and methods for controlling a cardiac resynchronisation device/therapy using biomarker panel data
08/08/2013WO2013116537A1 A method to distinguish benign from malignant oncocytic cell tissue
08/08/2013WO2013116523A1 Circulating tumor cell capturing techniques and devices
08/08/2013WO2013116455A1 Improved sensitivity and specificity for ovarian cancer
08/08/2013WO2013116385A1 Predictive biomarker for hypoxia-activated prodrug therapy
08/08/2013WO2013116371A1 Ex vivo plasma enzyme activity assay using inhibitors as a negative control
08/08/2013WO2013116331A1 Biomarkers for aggressive prostate cancer
08/08/2013WO2013116288A1 System and method for quantifying the presence of components in the exhaust of commercial and/or heavy-duty vehicles
08/08/2013WO2013116260A1 Selector based recognition and quantification system and method for multiple analytes in a single analysis
08/08/2013WO2013116210A1 Method for detecting polyomavirus reactivation
08/08/2013WO2013116088A1 Compositions and methods for detection of methodone metabolite
08/08/2013WO2013116012A1 A method and apparatus for testing lost circulation materials for subterranean formations
08/08/2013WO2013115962A2 Human streptococcus pneumoniae antibodies and uses therefor
08/08/2013WO2013115897A2 Pathogen detection using metal enhanced fluorescence
08/08/2013WO2013115885A2 Synthesizing functionalized dendrimers within biological settings
08/08/2013WO2013115867A1 Methods for identifying modulators of ras using nonlinear techniques
08/08/2013WO2013115772A2 Method and apparatus for detecting cancer in mammals
08/08/2013WO2013115725A1 A passive microfluidic device and a method of forming the same
08/08/2013WO2013115508A1 Method for screening therapeutic agent using transgenic drosophila expressing human dyrk1a gene
08/08/2013WO2013115425A1 Methods for screening an antibody by one-cycle panning
08/08/2013WO2013114885A1 Human monoclonal antibodies broadly protective against influenza b virus and methods of using the same
08/08/2013WO2013114817A1 Image processing apparatus, image processing system, image processing method, and program
08/08/2013WO2013114359A1 System and method for producing interleukin receptor antagonist (ira)
08/08/2013WO2013114333A1 Microfluidic flow analyzer for pathological detection and method thereof
08/08/2013WO2013114324A1 Device and/or duct for detecting fuel fed to an internal combustion engine
08/08/2013WO2013114304A2 Composition and sensor for detecting occult blood
08/08/2013WO2013114194A1 Measuring unit for determining the composition of the liquid phase in a multi-phase mixture
08/08/2013WO2013114175A1 Method for analysing the softness of a sheet of tissue paper
08/08/2013WO2013114064A1 Methods and devices for diagnosis of serious bacterial infection
08/08/2013WO2013113992A1 Method for determining liver fat amount and method for diagnosing nafld
08/08/2013WO2013113990A1 Separation of luminescent nanomaterials
08/08/2013WO2013113983A1 Mechanical washing and measuring device for performing analyses
08/08/2013WO2013113941A1 Cd8+t-cell subsets as markers for prediction of delayed fracture healing
08/08/2013WO2013113921A1 Method for obtaining integrated genomic, transcriptomic, proteomic and/or metabolomic information from a single unique biological sample
08/08/2013WO2013113755A1 Reagents and methods for the treatment of diseases based on the inhibition of calcineurin - nfat signalling pathway
08/08/2013WO2013113666A1 Device and method for recording contaminations in a hydraulic system
08/08/2013WO2013113663A1 Method for the detection of a binding partner of a multispecific binder
08/08/2013WO2013113641A1 Use of nkp46 as a predictive biomarker for cancer treatment with adcc- enhanced antibodies
08/08/2013WO2013113370A1 Gpcr with improved cell surface expression
08/08/2013WO2013113369A1 Cell based sensor
08/08/2013WO2013113127A1 Method of quantifying peptide-derivative libraries using phage display
08/08/2013WO2013113102A1 USE OF PDGFR-α AS DIAGNOSTIC MARKER FOR PAPILLARY THYROID CANCER
08/08/2013WO2013113092A1 Methods of determining cell mediated response
08/08/2013WO2013088348A3 Development of specific immunoassay critical reagents for pharmacokinetic assessments of peptide polymers in preclinical and clinical matrices
08/08/2013WO2013088140A3 Tenascin-c and use thereof in rheumatoid arthritis
08/08/2013WO2013087929A3 Method for identifying marker sequences for gynaecological malignant tumours
08/08/2013WO2013087601A3 Polyomavirus peptide sequences
08/08/2013WO2013080050A3 Methods and compositions for determining responsiveness to treatment with a tnf-alpha inhibitor
08/08/2013WO2013066986A8 Antibody response phenotyping
08/08/2013WO2013049782A9 System, apparatus and method for evaluating samples or analytes using a point-of-care device
08/08/2013WO2013032953A3 Development and use of fluorescent probes of unbound bilirubin
08/08/2013WO2012149936A3 System for identification of microorganism and detection of infectious disorder
08/08/2013WO2012149180A3 Fluorescent tracking dye
08/08/2013WO2012061741A3 Control and characterization of psychotic states
08/08/2013WO2012012377A3 Detector arrangement for blood culture bottles with colorimetric sensors
08/08/2013US20130205416 Anti-viral agent
08/08/2013US20130203871 Fuidi herd management schema
08/08/2013US20130203805 Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase
08/08/2013US20130203800 Method for detecting non-transferrin bound iron
08/08/2013US20130203798 Diagnosis and treatment of functional dyspepsia and irritable bowel syndrome
08/08/2013US20130203682 Rank ligand polypeptides
08/08/2013US20130203673 Glucagon-like peptide-2 analogs